NO PLACEBO FOR LOWER COSTS -- BY JEFF STIER AND HENRY I. MILLER, The Washington Times

But cuts could harm critical drug research

There must be a self-satisfied smirk on the face of the executives at big pharmaceutical companies as they watch congressional Democrats attempt to punish health insurance plans for having the nerve to raise questions about the consequences of current health reform proposals. Why? Because early on, Big Pharma cut a deal, paid up and bought itself some time.

CLICK TITLE OR HERE TO READ REMAINDER OF ARTICLE Sphere: Related Content